RNA, U6 small nuclear 408, pseudogene (RNU6-408P)

RNA, U6 small nuclear 408, pseudogene (RNU6-408P) is a pseudogene derived from U6 small nuclear RNA (snRNA), which itself is a highly conserved noncoding RNA critical in the spliceosome machinery for intron removal from pre-mRNA[3][1][5]. Pseudogenes like RNU6-408P are DNA sequences that resemble functional genes but have lost their protein-coding ability or ability to function as a primary transcript[2][4]. Although some pseudogenes can regulate gene expression through RNA interference or serve as competing endogenous RNAs, many are transcriptionally silent or nonfunctional, and there is no evidence that RNU6-408P has a distinct biological function or role as a therapeutic target[2][4]. Pseudogenes in general may serve as disease biomarkers or participate in gene regulation, especially in cancer, but such roles depend on the specific pseudogene and context[4]. RNU6-408P is not a receptor, enzyme, transporter, or known therapeutic target, and does not have established drug interactions or mechanisms of action. Key points: - RNU6-408P is a **pseudogene** of U6 snRNA, not an active RNA or protein target[2][3][4]. - **Not a therapeutic target:** It does not encode a receptor or enzyme, and is not used directly in drug discovery or therapy. - **Potential regulatory or biomarker roles** are known for some pseudogenes, but no specific functional evidence for RNU6-408P was identified in available literature. - **Is_incorrect: true** because: - This is not a canonical target (not a functional receptor, enzyme, transporter, or transcription factor). - No evidence supports its direct involvement in disease mechanisms or therapeutic intervention[2][4].

Other names

RNU6-408PU6 small nuclear RNA pseudogene 408U6 snRNA pseudogene 408